Peritoneal dialysis is a treatment for kidney failure that uses the lining of the patient’s abdomen, or belly, to filter the blood inside his/her body.
Market Dynamics
The rising prevalence of end stage renal disease and surge in demand for home dialysis treatment are anticipated to drive the peritoneal dialysis (PD) equipment segment.
Peritoneal dialysis is an effective form of dialysis, has been proven to be as good as hemodialysis. Peritoneal dialysis is not for everyone. People must receive training and be able to correctly perform each of the steps of the treatment. A trained helper may also be used. It is done more continuously than hemodialysis, resulting in less accumulation of potassium, sodium, and fluid. This allows patients to have a more flexible diet than could have on hemodialysis. Longer lasting residual kidney function.
Peritoneal dialysis can be done at home, at work or while traveling. Hemodialysis is typically done in a health care setting, such as a dialysis center or hospital, though it can sometimes be done at home. So peritoneal dialysis is more convincible than hemodialysis. Although both types of dialysis can effectively filter blood but people who use peritoneal dialysis might retain kidney function slightly longer than people who use hemodialysis.
Patients getting hemodialysis usually need treatments three times a week. Each treatment takes around four hours. While this may be inconvenient, many patients with low kidney function benefit from hemodialysis. Peritoneal dialysis is a good option for patients that meet certain health requirements and want fewer restrictions than they would have with hemodialysis.
Market Segmentation
By Product Type
• Peritoneal dialysis Machines
• Peritoneal Dialysis Concentrates/Dialysates
• Peritoneal Dialysis Catheters
By Type of Treatment
• Automated peritoneal dialysis (APD)*
• ous ambulatory peritoneal dialysis (CAPD)
By End User
• Home Health Care
• Hospitals
Geographical Analysis
Bases on Geographical Analysis, South America has the moderate growth rate in the region owing to increase in awareness about advanced dialysis devices among healthcare professionals & patients, developing healthcare infrastructure, and higher prevalence of ESRD. According to the Brazilian Chronic Dialysis Survey 2016 published by the Brazilian Society of Nephrology (SBN), on July 1, 2016, 92.1% of the patients on chronic renal replacement therapy and 7.9% were on peritoneal dialysis, the majority of whom on automated peritoneal dialysis (APD). Peritoneal dialysis was the mode of treatment for 7.7% of the patients served by the Brazilian public health care system (SUS) versus 9.0% of the individuals covered by private health insurance, driving the market demand for end-products. Although there is universal peritoneal dialysis coverage in Brazil, access to care is not uniform. Some patients with renal failure, particularly the oldest ones, those of lower social class, or those living far from health care centers with dialysis facilities (particularly in the north and northeast regions of the country), may not receive timely treatment. There is still considerable room for improvement regarding the integration of primary care facilities with more advanced health care centers.
Competitive Landscape
The peritoneal dialysis market is highly competitive. Some of the major players in the market include Baxter International, Fresenius Kabi AG, Medtronic, Utah Medical Products, Glomeria Therapeutics, Poly Medicure Ltd., Cook Medical Inc., CardioMed Supplies, Inc., Medical Components, Inc and Renax Biomedical Tech. Co., Ltd. In peritoneal dialysis market, companies are focusing on mergers and acquisitions and also on strategic moves to acquire greater market share.
The peritoneal dialysis market is competitive with the presence of few big firms and many small firms worldwide that have similar product offerings. Efficient distribution networks, product differentiation and supply competency play a major role in determining the market position of such players. Majority of these players are focusing on expanding distribution network as well as expanding presence in the Asia Pacific, Latin America and the Middle East regions due to increasing awareness and increasing disposable income. New Product Launches, partnerships, and acquisition are the major strategies adopted by the leading companies in the industry. The companies are heavily investing in the market to develop new products and are collaborating and acquiring other companies which help in increasing their market share.
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
